MX9803829A - Esteres de acido carboxilico aromatico, la produccion de los mismos y el uso de los mismos como medicamentos. - Google Patents

Esteres de acido carboxilico aromatico, la produccion de los mismos y el uso de los mismos como medicamentos.

Info

Publication number
MX9803829A
MX9803829A MX9803829A MX9803829A MX9803829A MX 9803829 A MX9803829 A MX 9803829A MX 9803829 A MX9803829 A MX 9803829A MX 9803829 A MX9803829 A MX 9803829A MX 9803829 A MX9803829 A MX 9803829A
Authority
MX
Mexico
Prior art keywords
same
alkyl
stands
medicaments
production
Prior art date
Application number
MX9803829A
Other languages
English (en)
Inventor
Michael Klaus
Peter Mohr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9803829A publication Critical patent/MX9803829A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen los compuestos de la formula (Ver Formula) en donde R1 significa hidrogeno o alquilo de 1 a 6 átomos de carbono; R2 significa alquilo de 1 a 6 átomos de carbono o adamantilo; R3 significa alquilo de 1 a 6 átomos de carbono o hidroxilo; o R2 y R3 conjuntamente significan -(CR6R7)N-; R1 significa alquilo de 2 a 9 átomos de carbono, alquenilo de 2 a 8 átomos de carbono, alquinilo de 2 a 8 átomos de carbono, -OCH2R5 o alcanoilo de 2 a 8 átomos de carbono; y si R3 es hidrogeno o hidroxi, R5 significa alquilo de 1 a 6 átomos de carbono, alquenilo de 2 a 6 átomos de carbono o alquinilo de 2 a 8 átomos de carbono; R4 y R7 significan hidrogeno o alquilo de 1 a 6 átomos de carbono; Y significa oxígeno o azufre; y n significa 3, 4 o 5, y las sales farmacéuticamente utilizables de los ácidos carboxílicos de la formula I que actuan como ligandos selectivos de los y-receptores del ácido retinoico, y pueden ser utilizados para el tratamiento de lesiones epiteliales.
MX9803829A 1995-11-16 1998-05-14 Esteres de acido carboxilico aromatico, la produccion de los mismos y el uso de los mismos como medicamentos. MX9803829A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH324995 1995-11-16

Publications (1)

Publication Number Publication Date
MX9803829A true MX9803829A (es) 1998-09-30

Family

ID=4251881

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9803829A MX9803829A (es) 1995-11-16 1998-05-14 Esteres de acido carboxilico aromatico, la produccion de los mismos y el uso de los mismos como medicamentos.

Country Status (16)

Country Link
US (2) US5726191A (es)
EP (1) EP0862554B1 (es)
JP (1) JP3061865B2 (es)
KR (1) KR100286190B1 (es)
CN (1) CN1137883C (es)
AT (1) ATE280159T1 (es)
AU (1) AU705849B2 (es)
BR (1) BR9611525A (es)
CA (1) CA2237313C (es)
DE (1) DE59611123D1 (es)
DK (1) DK0862554T3 (es)
ES (1) ES2230568T3 (es)
MX (1) MX9803829A (es)
PT (1) PT862554E (es)
TR (1) TR199800870T2 (es)
WO (1) WO1997018192A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2178B1 (en) * 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of invasive diseases, using selected anti-PAR materials
DK1351685T3 (da) * 2001-01-19 2008-04-28 Johnson & Johnson Consumer Stabiliserede formuleringer af selektive ligander af retinoinsyre-gamma-receptorer
EP1930005A1 (en) 2001-01-19 2008-06-11 Johnson and Johnson Consumer Companies, Inc. Stabilized formulation of selective ligands of retinoic acid gamma-receptors
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
PL2613776T3 (pl) 2010-09-01 2021-01-11 Thomas Jefferson University Kompozycja oraz sposób naprawy i regeneracji mięśni

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860716A (en) * 1971-04-06 1975-01-14 Smithkline Corp Methods and pharmaceutical compositions for inhibiting gluconeogenesis
DK158947C (da) * 1982-07-06 1991-01-21 Hoffmann La Roche Tetrahydronaphthalin-,benzofuran- og benzothiophenderivater, fremstilling og anvendelse deraf samt rodenticid indeholdende saadanne derivater
US4567184A (en) * 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
EP0170105B1 (en) * 1984-07-07 1990-10-17 Koichi Prof. Dr. Shudo Benzoic acid derivatives
FR2649977B1 (fr) * 1989-07-18 1991-10-04 Cird Esters bi-aromatiques, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
CA2119571A1 (en) * 1991-09-24 1993-04-01 Reinhard Sarges Retinoids and their use in treating skin diseases and leukemia
EP0617020A1 (en) * 1992-04-02 1994-09-28 Shudo, Koichi, Prof. Dr. Carboxylic acid derivatives having retinoic acid-like activity
AU691477B2 (en) * 1992-04-22 1998-05-21 Eisai R&D Management Co., Ltd. Compounds having selectivity for retinoid X receptors

Also Published As

Publication number Publication date
EP0862554A1 (de) 1998-09-09
BR9611525A (pt) 1999-07-13
JPH11500452A (ja) 1999-01-12
CN1137883C (zh) 2004-02-11
DE59611123D1 (de) 2004-11-25
EP0862554B1 (de) 2004-10-20
PT862554E (pt) 2005-01-31
AU7275996A (en) 1997-06-05
ES2230568T3 (es) 2005-05-01
KR100286190B1 (ko) 2001-04-16
US5726191A (en) 1998-03-10
CN1202154A (zh) 1998-12-16
AU705849B2 (en) 1999-06-03
KR19990067645A (ko) 1999-08-25
CA2237313C (en) 2006-04-25
TR199800870T2 (xx) 1998-07-21
WO1997018192A1 (de) 1997-05-22
ATE280159T1 (de) 2004-11-15
DK0862554T3 (da) 2005-02-14
US5958956A (en) 1999-09-28
CA2237313A1 (en) 1997-05-22
JP3061865B2 (ja) 2000-07-10

Similar Documents

Publication Publication Date Title
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
CA2268886A1 (en) Aminothiophenecarboxamides
MX9701292A (es) Compuestos espiro-azabiciclicos utiles en la terapia.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
TR199801642T2 (xx) Tedavide faydal� olan karbamik asitlerin azabisiklik esterleri.
CA2263561A1 (en) Thienopyrimidines
MX9702658A (es) Derivados novedosos de acido carboxilico, su preparacion y uso.
GEP20043315B (en) Non-Peptide GnRH Agents, Methods For Their Preparation and Use Thereof
NZ514487A (en) Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
CA2311922A1 (en) Thienopyrimidines
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
GEP20022654B (en) Indazole Amide Compounds As Serotoninergic Agents
MX9803829A (es) Esteres de acido carboxilico aromatico, la produccion de los mismos y el uso de los mismos como medicamentos.
IL114754A0 (en) Benzimidazole derivatives
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
AU5064393A (en) Novel medicaments containing imidazol-1-yl compounds
TR199701202T1 (xx) Yeni hidroksimik asit t�revleri.
ES2010736A6 (es) Procedimiento para preparar nuevos derivados del acido furanuronico.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
AU8625598A (en) Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
CA2130678A1 (en) 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof
TR199701604T2 (xx) Pirol t�revleri i�in yeni ba�vuru